Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

UPDATED: In management reorg, Teva taps Actavis alum to helm new global generics unit

Teva Pharmaceutical Industries CEO Erez Vigodman has been a busy man. So busy, in fact, it seems the company's press releases barely keep up with him. Today's announcement: Vigodman has overhauled Teva's management structure, winnowing out 6 executive jobs and creating two worldwide divisions. And he recruited a pharma-industry vet to take the helm of one of them.

Novartis nabs Merck exec Bruno Strigini to head up oncology business

Novartis wooed one of Merck & Co.'s top executives to take the helm at its oncology unit.

Metabolic disease, cardio expert joins Pfizer's R&D team

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Former CDER official joins Greenleaf Health, biosimilars experience in tow

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Who's going to run Celgene when Hugin hangs it up?

With Celgene CEO Bob Hugin working through his 15th year at the company, an internal race to spot his eventual successor appears to be in progress, and the Big Biotech's latest round of promotions provides some clues to its future leadership.

Forest CEO Saunders to lead combined company after Actavis buyout

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Prepping for $25B merger, Actavis taps Forest CEO Saunders to lead combined company

When Actavis CEO Paul Bisaro announced his big buyout of Forest Laboratories, he sketched a picture of a brand-plus-generic powerhouse with lower costs and bigger revenue prospects. Now, it will be Forest CEO Brent Saunders who colors in those lines as chief executive of the merged company.

Bristol-Myers' senior VP of global development retires

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Endo appoints former Bausch + Lomb exec to head corporate strategy

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Actavis global R&D president departs to helm Impax Labs

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...